40 results on '"Rhinn, Herve"'
Search Results
2. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
3. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders
4. Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
5. Additional file 1 of Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
6. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease.
7. Progranulin as a therapeutic target in neurodegenerative diseases
8. A Phase 2 Study of AL001 in Frontotemporal Dementia Patients Carrying a Granulin Mutation (P5-3.005)
9. A Phase 1 Study of AL003 in Healthy Volunteers and Participants with Alzheimer’s disease (P5-3.002)
10. A Phase 1 Study of AL002 in Healthy Volunteers (P5-3.004)
11. A phase 1 study of AL002 in healthy volunteers
12. Six months interim analysis of the phase 2 study of AL001 in frontotemporal dementia patients carrying a granulin mutation
13. Multi-tissue proteomics identifies molecular signatures for sporadic and genetically defined Alzheimer disease cases
14. PARKINSONʼS DISEASE: Guilt by genetic association: Certain sequence variants of the α-synuclein gene are linked to the risk of Parkinsonʼs disease. An analysis of these variants using gene-editing technology provides a possible explanation for this increased risk. See Letter p.95
15. Integrative genomics identifies APOE ζ4 effectors in Alzheimer's disease
16. Guilt by genetic association
17. Identification of multi‐issue protein quantitative trait loci (pQTLs) for Alzheimer disease
18. AL001 restores CSF PGRN levels and normalizes disease‐associated biomarkers in individuals with frontotemporal dementia due to heterozygous mutations in the progranulin gene
19. Proteogenomic analysis of cerebrospinal fluid reveals causal role of proteins from the autophagy‐lysosome pathway in Parkinson’s disease
20. Integrative genomics identifies APOE ε4 effectors in Alzheimerʼs disease
21. Genomic and multi-tissue proteomic integration for understanding the biology of disease and other complex traits
22. Shifting paradigms: The central role of microglia in Alzheimer's disease
23. Genome-wide association, Mendelian Randomization and polygenic risk score studies converge on a role of β−amyloid and APOE locus in Parkinson disease
24. Genomic and multi-tissue proteomic integration for understanding the biology of disease and other complex traits
25. O1‐08‐04: PRECLINICAL DEVELOPMENT OF TREM2 AGONIST ANTIBODY (AL002) IN CYNOMOLGUS MONKEYS
26. O1‐08‐02: DEVELOPMENT OF TREM2 AGONISTIC ANTIBODIES TO TREAT ALZHEIMER'S DISEASE
27. Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes
28. PRECLINICAL DEVELOPMENT OF TREM2 AGONIST ANTIBODY (AL002) IN CYNOMOLGUS MONKEYS
29. DEVELOPMENT OF TREM2 AGONISTIC ANTIBODIES TO TREAT ALZHEIMER’S DISEASE
30. Retraction: integrative genomics identifies APOE [epsilon]4 effectors in Alzheimer's disease
31. Retraction Note: Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease
32. Retraction Notice to: Directed Conversion of Alzheimer’s Disease Patient Skin Fibroblasts into Functional Neurons
33. RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk
34. One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler
35. Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology
36. RETRACTED: Directed Conversion of Alzheimer's Disease Patient Skin Fibroblasts into Functional Neurons
37. Identification and Induction of Cytochrome P450s Involved in the Metabolism of Flavone-8-Acetic Acid in Mice
38. Multi‐tissue proteomic profiling for genetically defined Alzheimer disease cases.
39. Retraction: Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease.
40. Directed Conversion of Alzheimer's Disease Patient Skin Fibroblasts into Functional Neurons
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.